Long-term oral acyclovir treatment prevents recurrent genital herpes.

Author: BlomI, BäckO, EgelrudT, FrödinT, HellbeL, JohannissonG, Malmros-EnanderI, MolinL

Paper Details 
Original Abstract of the Article :
Thirty-three patients with frequently recurring genital herpes completed a randomized double-blind, crossover trial with oral acyclovir 200 mg 4 times a day and placebo for periods of 12 weeks. Five patients (15%) had full recurrence during acyclovir treatment and 31 (94%) while receiving placebo. T...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000249257

データ提供:米国国立医学図書館(NLM)

Herpes: A Recurring Cycle of Pain and Relief

Genital herpes, a recurring viral infection, can be a frustrating and recurring challenge, like a desert sandstorm that keeps returning. This study investigates the effectiveness of long-term oral acyclovir treatment in suppressing recurrent genital herpes.

The researchers conducted a double-blind, crossover trial, comparing acyclovir to placebo. The results revealed that acyclovir was effective in suppressing herpes outbreaks during the treatment period. However, when acyclovir treatment was discontinued, the rate of recurrence returned to its previous level.

Beyond the Sands: Understanding the Limits of Treatment

This research reveals the complex nature of herpes and the limitations of current treatments. While acyclovir can effectively suppress outbreaks, it does not cure the infection. It highlights the need for ongoing management strategies to control recurrent outbreaks and minimize the impact of herpes on an individual's life.

Finding Oasis in the Desert of Herpes

This research underscores the importance of working closely with a healthcare professional to manage genital herpes. While acyclovir can be an effective tool, it is important to understand its limitations and explore other management strategies. This research emphasizes the need for continued research and development of new treatments to effectively manage herpes and prevent recurrent outbreaks, providing individuals with more lasting relief and a better quality of life.

Dr.Camel's Conclusion

This research reminds us that the desert of herpes can be a recurring and challenging experience. While acyclovir offers a valuable tool for managing outbreaks, it is important to understand its limitations and explore other management strategies. It is a testament to the ongoing search for more effective treatments to combat this persistent viral infection and bring lasting relief to those affected.

Date :
  1. Date Completed 1987-02-27
  2. Date Revised 2019-09-03
Further Info :

Pubmed ID

3100353

DOI: Digital Object Identifier

10.1159/000249257

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.